Vasopressin-induced bullous disease and cutaneous necrosis

1986 ◽  
Vol 15 (2) ◽  
pp. 393-398 ◽  
Author(s):  
Robert J. Korenberg ◽  
Debra Landau-Price ◽  
Neal S. Penneys
Keyword(s):  
Cutaneous Necrosis ◽  
Bullous Disease

Chronic bullous disease of childhood following Epstein-Barr virus seroconversion: a case report

1996 ◽  
Vol 21 (2) ◽  
pp. 123-126
Author(s):  
U. BALDARI ◽  
A. ASCARI RACCAGNI ◽  
B. CELLI ◽  
M. GIOVANNA RIGHINI
Keyword(s):  
Case Report ◽  
Epstein Barr Virus ◽  
Barr Virus ◽  
Bullous Disease ◽  
Epstein Barr

Bullous disease of childhood

1971 ◽  
Vol 104 (4) ◽  
pp. 454b-454
Author(s):  
R. D. Griesemer
Keyword(s):  
Bullous Disease

Mixed bullous disease

1979 ◽  
Vol 115 (7) ◽  
pp. 816-816 ◽  
Author(s):  
M. J. Fellner
Keyword(s):  
Bullous Disease

Extensive cutaneous necrosis in infective endocarditis: do not forget rare causes

2019 ◽  
Vol 41 (24) ◽  
pp. 2337-2337
Author(s):  
Maks Mihalj ◽  
Miralem Pasic ◽  
Thierry Carrel
Keyword(s):  
Infective Endocarditis ◽  
Cutaneous Necrosis

scholarly journals A case of cutaneous necrosis due to intra-articular hyaluronic acid and treated with hyaluronidase

2021 ◽  
Vol 9 ◽  
pp. 2050313X2110251
Author(s):  
Michelle Aaron ◽  
Yu Qing Huang ◽  
Danielle Bouffard ◽  
Jean-Pascal Costa ◽  
Benoît Côté
Keyword(s):  
Hyaluronic Acid ◽  
Initial Treatment ◽  
Treatment Approach ◽  
Clinical State ◽  
Dermal Fillers ◽  
Ankle Osteoarthritis ◽  
Cutaneous Necrosis ◽  
Hyaluronic Acid Injection ◽  
First Time ◽  
Ankle And Foot

A 66-year-old woman presented to the hospital with cutaneous necrosis of her right ankle and foot. Her symptoms began immediately after an intra-articular injection of hyaluronic acid for ankle osteoarthritis, which was performed 6 days before. Histopathology showed an intra-vascular hyaluronic acid embolus. The initial treatment approach was conservative, but the patient’s clinical state degraded. She was thus treated with sub-cutaneous hyaluronidase, the enzyme that degrades hyaluronic acid, which yielded a moderate improvement even though it was administered 22 days after the initial hyaluronic acid injection. Although hyaluronic acid embolism and subsequent cutaneous necrosis are well-known complications of dermal fillers, there are few reported cases of embolism following intra-articular injection. To our knowledge, this is the first time hyaluronidase has been used in this setting.

Sign in / Sign up

Export Citation Format

Share Document